Boron neutron capture therapy of brain tumors: literature review
Keywords:
Boron neutron capture therapy, brain tumor, boron-containing drugsAbstract
The paper provides the modern information about the method of boron neutron capture therapy of brain tumors. Current status of the problem, actual questions of development and clinical application of BNCT, future prospect are considered.
References
Зозуля Ю.А., Розуменко В.Д., Лисяный Н.И. Проблемы современной нейроонкологии // Журн. АМН України. —1999. — т. 5, № 3. — С. 426—441.
Розуменко В.Д. Принципы оказания помощи при неотложных состояниях в нейроонкологии // Укр. Мед. альманах. —1999. — Т.2, №3 (додаток). — С.87—90.
Barth R.F., Adams D.M., Soloway A.H. et al. Boronated starburst dendrimer-monoclonal antibody immunoconjugates: Evaluation as a potential delivery system for neutron capture therapy // Bioconjug. Chem. —1994. — V.5. — P.58—66.
Barth R.F., Soloway A.H., Brugger R.M. Boron neutron capture therapy of brain tumors: past history, current status, and future potential // Cancer Invest. —1996. — V.14, N6. — P.534—550.
Barth R.F., Soloway A.H., Goodman J.H. et al. Boron neutron capture therapy of brain tumors: an emerging therapeutic modality// Neurosurgery. —1999. — V.44, N3. — P.433—451.
Barth R.F., Yang W., Bartus R.T. et al. Enchanced delivery of boronophenylalanine for neutron capture therapy of brain tumors using the bradykinin analog Cereport (Receptor-Mediated Permeabilizer—7) //Neurosurgery. —1999. — V.44, N2. — P.351—360.
Beddoe A.H. Boron neutron capture therapy //Br. J. Radiol. —1997. — V.70. — P.665—667.
Cai J., Soloway A.H., Barth R.F. et al. Boron-containing poliamines as DNA targeting agents for neutron capture therapy of brain tumors: synthesis and biological evaluation // J. Med. Chem. —1997. — V.40. — P.3887—3896.
Capala J., Barth R.F., Bendayan M. et al. Boronated epidermal growth factor as a potential targeting agent for boron neutron capture therapy of brain tumors // Bioconjug. Chem. —1996. — V.7. — P.7—15.
Carlsson J., Gedda L., Gronvik C. et al. Strategy for boron neutron capture therapy against brain tumor cells with over-expression of the epidermal growth factor receptor // Int. J. Radiat. Oncol. Biol. Phys. —1993. — V.30. —105—115.
Catterall M. , Bloom J.G., Ash D.V. et al. Fast neutrons compared with megavoltage X-Rays in the treatment of patients with supratentorial glioblastoma: a controlled pilot study // Int. J. Radiat. Oncol. Biol. Phys. —1980. — V.6. — P.261—266.
Central Brain Tumor Registry of theUnited States. —1990.
Central Brain Tumor Registry of theUnited States. —1995.
Central Brain Tumor Registry of theUnited States. —1998.
Chadha M., Capala J., Coderre J.A. et al. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory // Int. J. Radiat. Oncol. Biol. Phys. —1998. — V.40. — P.829—834.
Coddere J.A., Elowitz E.H., Chadha M. Et al. Boron neutron capture therapy for glioblastoma multiforme using p-boronophenylalanine and epithermal neutrons Trial design and early clinical results // J. Neurooncol. —1997. — V.33. — P.141—152.
Curran W.J., Scott C.B., Horton J. et al. Recursive Partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials // J. Nat. Cancer Inst. —1993. — V.85,N9. — P.704—710.
Drollette D. Optical fiber could revive troubled cancer treatment //Biophotonics Intern. —2000. — N 1—2. — P.46—49.
Elowitz E.H., Bergland R.M., Coderre J.A. et al. Biodistribution of p-boronophenylalanine in patients with glioblastomas multiforme for use in boron neutron capture therapy // Neurosurgery. —1998. — V.42. — P.463—469.
Fallot T., Magdelena T.H., Mady E. et al. A phase I study of an antiepidermal growth factor receptor monoclonal antibody for the treatment of malignant gliomas // Neurosurgery. —1996. — V.39. — P.478—483.
Feakes D.A., Shelly K., Hawthorne M. et al. Selective boron delivery to murine tumors by lipophilic species incorporated in the membranes of unilamellar liposomes // Proc. Nat. Acad. Sci. USA. —1995. — V.92. — P.1367—1370.
Feinendegen L.E. Strategic planning workshop on research needs for neutron capture therapy // J. Neurooncol. —1997. — V.33. — N1—2. — P.179—185.
Fine H.A. The basis for current treatment recommendations for malignant gliomas // J.Neurooncol. —1994. — V.20. -N2. -P.11—120.
Gabel D., Foster S., Fairchild R.G. The Monte Carlo simulation of the biological effect of the 10B (n,a) 7Li reaction in cells and tissue and its implication for boron neutron capture therapy // Radiat. Res. —1987. — V.111. — P.25—36.
Greig N, Ries L. Increasing annual incidence of primary malignant brain tumors in the elderly// J. Nat. Cancer Inst. —1990. — V. 82. — P. 1621—1623.
Hariharan J.R., Wyzlic I.M., Soloway A.H. Synthesis of novel boron-containing polyamines agent for DNA targeting in neutron capture therapy // Polyhedron. —1995. — V.14. — P.823—825.
Haselsberger K., Radner H., Pendl G. Boron neutron capture therapy for glioblastoma: improvement of boron biodistribution by hyaluronidase // Cancer Lett. —1998. — V.131. — P.109—111.
Hatanaka H. Clinical results of boron neutron capture therapy // Basic. Life Sci. —1990. — V.54. — P. 15—21.
Hatanaka H. Experience of boron neutron capture therapy for malignant brain tumours with special reference to the problems of postoperative CT follow-ups // Acta Neurochir. Suppl. (Wien). —1988. — V.42. — P.187—192.
Hawthorne M.F. The role of Chemistry in the development of boron neutron capture therapy of cancer // Angew. Chem. Int. Ed. Engl. —1994. — V.32. — P.950—984.
Hideghety K., Sauerwein W., Haselsberger K. et al. Postoperative treatment of glioblastoma with BNCT at the petten irradiation facility // Strahlentherapie Oncol. —1999. — V.175. — Suppl. 2. — P.111—114.
Hill J.S., Kahl S.B., Kaye A.H. et al. Selective tumor uptake of boronated porphyrin in an animal model of cerebral glioma // Proc. Nat. Acad. Sci. USA. —1992. — V.89. — P.1785—1789.
Hill J.S., Kahl S.B., Stylli S.S. et al. Selective tumor kill of cerebral glioma by photodynamic therapy using a boronated porphyrin photosensitizer // Proc. Nat. Acad. Sci. USA. —1995. — V.92. — P.12126—12130.
Javid M., Brownell G.L., Sweet W.H. The possible use of neutron capture isotopes such as boron—10 in the treatment of neoplasms: II — Computation of the radiation energy and estimates of effects in normal and neoplastic brain // J. Clin. Invest. —1952. — V.31. — P.603—610.
Joel D.D., Coderre J.A., Micca P.L., Nawrocky M.M. Effect of dose and infusion time on the delivery of p-boronophenylalanine for neutron capture therapy // J.Neurooncol. —1999. — V.41, N3. — P.213—221.
Kabalka G.W., Tang C., Bendel P. The role of boron MRI in boron neutron capture therapy // J. Neurooncol. —1997. — V.33, N 1—2. — P.153—161.
Kahl S.B., Pate D.W., Waunschel L.A. Low density lipoprotein reconstitution with alkyl and aryl carboranes // Soloway A.H., Barth R.F., Carpenter D.E. (ed). Advances in Neutron Capture Therapy. — New York: Plenum Press, 1993. — P.399—402.
Kneschaurek P., Weissfloch L. Boron neutron capture therapy // Biomed. Tech. (Berl.). —1997. — V.42. — P.31—33.
Kobayasshi T., Kanda K. Analytical calculation of boron—10 dosage in cell nucleus for neutron capture therapy // Radiat. Res. —1982. — V.91. — P.77—94.
Kobayasshi T., Kanda K. Microanalysis system of ppm-order 10B concentrations in tissue for neutron capture therapy by prompt gamma-ray spectrometry // Nucl. Instr. Meth. —1983. — V.204. — P.96—103.
Kurup P.D., Pajak T.F., Nelson J.S. et al. Fast neutron therapy for malignant astrocytomas // J. Neurooncology. —1986. — V.4. — P.123—129.
Laramore G.E., Diener-West M., Griffin T.W. et al. Randomized neutron dose searching study for malignant gliomas of the brain: Results of an RTOG study // Int. J. Rad. Onc. Biol. Phys. —1988. -V.14. — P.1093—1102.
Laramore G.E., Griffin T.W., Gerdes A.J. et al. Fast neutron and mixed (neutron/proton) beam teletherapy for grades III and IV astrocytoma // Cancer. —1978. — V.42. — P.96—103.
Latif A.Z.B., Signorini D., Gregor A. et al. Application of the MRC brain tumour prognostic index to patients with malignant glioma not managed in randomised control trial //J. Neurol. Neurosurg. Psychiatry. —1998. — V.64. — P.747—750.
Laws E., Kamat T. Brain Tumors // A Cancer Journal for Clinicians. —1993. — V. 43. — P. 263—265.
Legler J., Ries L., Smith M. et al. Brain and other central nervous system cancers: recent trends in incidence and mortality // J. Nat. Cancer Inst. —1999. — V. 91, N 16.
Liu L., Barth R.F., Adams D. et al. Critical evaluation of bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors // Anticancer Res. —1996. — V.16. — P.2581—2588.
Matsumoto T. Evaluation of dept-dose distributions for gadolinium neutron capture therapy // Soloway A.H., Barth R.F., Carpenter D.E. (eds). Advances in neutron capture therapy. New York: Plenum Press, 1993. — P.235—240.
Mishima Y. Selective thermal neutron capture therapy of cancer cells using their specific metabolic activies-melanoma as prototype // Cancer Neutron Capture Therapy. — New York: Plenum Press, 1996. — P.1—26.
Mishima Y., Honda C., Ichihashi M. et al. Treatment of malignant melanoma by single neutron capture treatment with melanoma-seeking 10B compound // Lancet.- 1989. — P.388—389.
Miura M., Micca P.L., Fisher C.D. et al. Evalution of carborane-containing porphyrins as tumor targeting agents for boron neutron capture therapy // Br. J. Radiol. —1998. — V.71. — P.773—781.
Munday A.D., Sriratana A., Hill J.H. et al. Mitochondria are the functional intracellular target for photosensitizing boronated porphyrin // Biochem. Biophys. Acta. —1996. -V.1311. — P.1—4.
Murzin A.V. et al. Reactor filtered neutron beams for astrophysical and BNCT investigations // IX International Symposium on Capture Rays Spectroscopy and related Topics. — Budapest, 1996. — P.850—853.
Nakagawa Y., Hatanaka H. Boron neutron capture therapy: Clinical brain tumor studies // J.Neurooncol. —1997. — V.33. — P.105—115.
Nigg D.W., Wheeler F.J., Wessol D.E. et al. Computetional dosimetry and treatment planning for boron neutron capture therapy // J. Neurooncol. —1997. -V.33. — P.93—104.
Rong F.G., Soloway A.H. Synthesis of 5-tethered carbone-containing pyramidine nucleosides as potential agents for DNA incorporation // Nucleosides & Nucleotides. —1994. — V.13. — P.2021—2034.
Rong F.G., Soloway A.H., Ikeda S., Ives D.H. Synthesis and biochemical activity of hydrophilic carborane-containing pyrimidine nucleosides as potential agents for DNA incorporation and BNCT // Nucleosides & Nucleotides. —1997. — V.16. — P.379—401.
Scobie M., Threadgill M.D. Synthesis of carborane-containing nitroimidazole compounds via mild 1.3-dipolar cycloaddition //J.Chem. Soc. Comm. —1992. — P.939—941.
Shibata Y, Matsumura A, Yamamoto T. et al. Neutron capture therapy with a new boron-porphyrin compound in the rat 9L glioma model // J. Exp. Clin. Cancer. Res. —1998. — V.17, N 3. — P.285—289.
Shil J.A., Brugger R.M. Gadolinium as a neutron capture therapy agent //Med. Phys. —1992. — V.19, N3.
Sjoberg S., Carlsson J., Ghaneolhosseini H. et al. Chemistry and biology of some low molecular weight boron compounds boron neutron capture therapy // J. Neutooncol. —1997. — V.33. — P.41—52.
Slatkin D.N. A history of boron neutron capture therapy of brain tumors // Brain. —1991. — V.114. — P.1609—1629.
Snyder H.R., Reedy A.J., Lennarz W.J. Synthesis of aromatic boronic acids, aldehydo boronic acids and a boronic acid analog of tyrosine // J. Am. Chem. Soc. —1958. — V.80. — P.835—838.
Soloway A.H., Barth R.F., Alam F. et al. Delivery of boron—10 for neutron capture therapy by means of chemical compounds and antibodies // Hatanaka H. (ed) Boron Neutron Capture Therapy for tumors. — Niigata, Nishimura Co, 1986. — P.47—58.
Soloway A.H., Barth R.F., Gahbauer R.A. et al. The rationale and requirements for the development of boron neutron capture therapy of brain tumors // J.Neurooncol. —1997. — V.33. — P.9—18.
Soloway A.H., Hatanaka H., Davis M.A. Penetration of brain and brain tumor: VII — Tumor-binding sulfhydryl boron compounds // J. Med. Chem. —1967. — V.10. — P.714—717.
Soloway A.H., Tjarks W., Barnum B.A. et al. The chemistry of neutron capture therapy // Chem. Rev. —1998. — V.98. — P.1515—1562.
Spielvogel B.F., Soad B.F., Soad A., Powell W. et al. Chemical and enzymatic incorporation of boron into DNA // Soloway A.H., Barth R.F., Carpenter D.E. (eds). Advances in Neutron Capture Therapy. — New York: Plenum Press, 1993. — P. 389—393.
Sweet W.H. Early history of development of boron neutron capture therapy of tumors // J. Neurooncol. —1997. — V.33. — P.19—26.
Taylor S.A. New agents in the treatment of primary brain tumors // J.Neurooncol. —1994. — V.20, N2. — P141—153.
Tjarks W., Malmquist J., Gedda L. et al. Synthesis and initial biological evaluation of carborane-containing phenanthrifinum derivatives // Sixth Int. Symp. on Neutron Capture Therapy for Cancer. Kobe (31 Oct.—4 Nov.,1994). —1994. — P.112.
Tolpin E.L., Wellum G.R., Dohan F.C. et al. Boron neutron capture therapy of cerebral gliomas: II — Utilization of the blood-brain barrier and tumor-specific antigens for the selective concentrations of boron in gliomas // Oncology. —1975. — V.32. — P.223—246.
Vertosick F.T. Brain tumor biology and therapy // Curr. Opin. Neurol. Neurosurg. —1991. — V.4, N1. — P.24—28.
Wagner F.M., Koester L., Wehrmann R. et al. The fast neutron facility at the research reactor Munich: determination of the beam quality and medical applications // IX International School on Nuclear Physics, Neutron Physics and Nuclear Energy. — Varna, 28 Sep. —7 Oct., 1989.
Wang C.K., Blue T.E., Gahbauer R. A neutronic study of an accelerator-based neutron irradiation facility for boron neutron capture //Nucl. Technol. —1989. — V.84. — P.93—107.
Wyzlic I.M., Tjarks W., Soloway A.H. et al. Strategies for the drsign and synthesis of boronated nucleic acid and protein components as potential delivery agents for neutron capture therapy // Int. J. Radiat. Oncol. Biol. Phys. —1994. — V.28. — P. 1203—1213.
Yanch J.C., Zhou X.I., Shefer R.E. et al. Accelerator-based epithermal neutron beam design for neutron capture therapy // Med. Phys. —1992. — V.19. — P.709—722.
Yang W., Barth R.F., Adams D.A., Soloway A.H. Intratumoral delivery of boronated epidermal growth factor for neutron capture therapy of brain tumors // Cancer. Res. —1997. — V.57. — P.4333—4339.
Year 2000 Standard Statistical Report // Central Brain Tumor Registry of the United States, 1999. — P. 7—18.
Zamenhof R.G. Microdosimetry for boron neutron capture therapy: A review // J. Neurooncol. —1997. — V.33. — P.78—92.
Zhuo J.C., Cai J., Soloway A.H. et al. Synthesis and biological evaluation of boron-containing polyamines as potential agents for neutron capture therapy of brain tumors // J. Med. Chem. —1999. — V.42, N7. — P. 1282—1292.
Zuo C.S., Prasad P.V., Busse P. Et al. Proton nuclear magnetic resonance measurement of p-boronphenylalanine (BPA): a therapeutic agent for boron neutron capture therapy // Med. Phys. —1999. — V.26, N7. — P. 1230—1236.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2001 Volodymyr Rozumenko
This work is licensed under a Creative Commons Attribution 4.0 International License.
Ukrainian Neurosurgical Journal abides by the CREATIVE COMMONS copyright rights and permissions for open access journals.
Authors, who are published in this Journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the Journal under the terms of Creative Commons Attribution License, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this Journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form of which it has been published by the Journal (for example, to upload the work to the online storage of the Journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this Journal is included.
